222 related articles for article (PubMed ID: 31883678)
1. Usefulness of High-Sensitivity Troponin I to Predict Outcome in Patients With Newly Detected Atrial Fibrillation.
Kim BS; Kwon CH; Chang H; Kim SH; Kim HJ; Hwang HK; Chung SM
Am J Cardiol; 2020 Mar; 125(5):744-750. PubMed ID: 31883678
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Hijazi Z; Siegbahn A; Andersson U; Granger CB; Alexander JH; Atar D; Gersh BJ; Mohan P; Harjola VP; Horowitz J; Husted S; Hylek EM; Lopes RD; McMurray JJ; Wallentin L;
Circulation; 2014 Feb; 129(6):625-34. PubMed ID: 24226808
[TBL] [Abstract][Full Text] [Related]
3. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Alexander JH; Atar D; Gersh BJ; Hanna M; Harjola VP; Horowitz JD; Husted S; Hylek EM; Lopes RD; McMurray JJ; Granger CB;
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):52-61. PubMed ID: 24055845
[TBL] [Abstract][Full Text] [Related]
4. High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study.
Jia X; Sun W; Hoogeveen RC; Nambi V; Matsushita K; Folsom AR; Heiss G; Couper DJ; Solomon SD; Boerwinkle E; Shah A; Selvin E; de Lemos JA; Ballantyne CM
Circulation; 2019 Jun; 139(23):2642-2653. PubMed ID: 31030544
[TBL] [Abstract][Full Text] [Related]
5. The association of cardiac troponin and cardiovascular events in patients with concomitant heart failure preserved ejection fraction and atrial fibrillation.
Kim BS; Kwon CH; Chang H; Choi JH; Kim HJ; Kim SH
BMC Cardiovasc Disord; 2023 May; 23(1):273. PubMed ID: 37226163
[TBL] [Abstract][Full Text] [Related]
6. Association of High-Sensitivity Troponin I with Cardiac and Cerebrovascular Events in Patient after Ischemic Stroke.
Kim BS; Park JJ; Chang H; Kim SH; Kwon CH; Chung SM; Kim HY; Kim HJ
Cerebrovasc Dis; 2023; 52(2):153-159. PubMed ID: 35908539
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation).
Hijazi Z; Wallentin L; Siegbahn A; Andersson U; Christersson C; Ezekowitz J; Gersh BJ; Hanna M; Hohnloser S; Horowitz J; Huber K; Hylek EM; Lopes RD; McMurray JJ; Granger CB
J Am Coll Cardiol; 2013 Jun; 61(22):2274-84. PubMed ID: 23563134
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the Association Between High-Sensitivity Troponin I and Adverse Cardiovascular Outcomes in Patients With Versus Without Chronic Kidney Disease.
Sandesara PB; O'Neal WT; Tahhan AS; Hayek SS; Lee SK; Khambhati J; Topel ML; Hammadah M; Alkhoder A; Ko YA; Gafeer MM; Beshiri A; Murtagh G; Kim JH; Wilson P; Shaw L; Epstein SE; Sperling LS; Quyyumi AA
Am J Cardiol; 2018 Jun; 121(12):1461-1466. PubMed ID: 29628129
[TBL] [Abstract][Full Text] [Related]
9. Relative Prognostic Value of Cardiac Troponin I and C-Reactive Protein in the General Population (from the Nord-Trøndelag Health [HUNT] Study).
Sigurdardottir FD; Lyngbakken MN; Holmen OL; Dalen H; Hveem K; Røsjø H; Omland T
Am J Cardiol; 2018 Apr; 121(8):949-955. PubMed ID: 29496193
[TBL] [Abstract][Full Text] [Related]
10. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network.
Fudim M; Ambrosy AP; Sun JL; Anstrom KJ; Bart BA; Butler J; AbouEzzeddine O; Greene SJ; Mentz RJ; Redfield MM; Reddy YNV; Vaduganathan M; Braunwald E; Hernandez AF; Borlaug BA; Felker GM
J Am Heart Assoc; 2018 Dec; 7(24):e010364. PubMed ID: 30561266
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of troponin I in atrial fibrillation.
Quesada A; López-Valero L; Marcaida-Benito G; Bello JJ; Quesada-Ocete J; Rubini-Costa R; Quesada-Ocete B; Rubini-Puig R; Férez-Martí A; Del Moral-Ronda V; Palanca-Gil V; de la Guía-Galipienso F; Lavie CJ; Lippi G; Sanchis-Gomar F
Prog Cardiovasc Dis; 2021; 67():80-88. PubMed ID: 33639172
[TBL] [Abstract][Full Text] [Related]
12. Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a Randomized Evaluation of Long-term Anticoagulation Therapy (RE-LY) substudy.
Hijazi Z; Oldgren J; Andersson U; Connolly SJ; Ezekowitz MD; Hohnloser SH; Reilly PA; Vinereanu D; Siegbahn A; Yusuf S; Wallentin L
Circulation; 2012 Apr; 125(13):1605-16. PubMed ID: 22374183
[TBL] [Abstract][Full Text] [Related]
13. Impact of atrial fibrillation on levels of high-sensitivity troponin I in a 75-year-old population.
Horjen AW; Ulimoen SR; Enger S; Berge T; Ihle-Hansen H; Norseth J; Tveit A
Scand J Clin Lab Invest; 2015 Jul; 75(4):308-13. PubMed ID: 25761493
[TBL] [Abstract][Full Text] [Related]
14. Association between cardiac troponin I and mortality in patients with COVID-19.
Salvatici M; Barbieri B; Cioffi SMG; Morenghi E; Leone FP; Maura F; Moriello G; Sandri MT
Biomarkers; 2020 Dec; 25(8):634-640. PubMed ID: 33003961
[TBL] [Abstract][Full Text] [Related]
15. Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY Trial.
Hijazi Z; Verdecchia P; Oldgren J; Andersson U; Reboldi G; Di Pasquale G; Mazzotta G; Angeli F; Eikelboom JW; Ezekowitz MD; Connolly SJ; Yusuf S; Wallentin L
J Am Heart Assoc; 2019 Jan; 8(2):e010107. PubMed ID: 30651032
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic and prognostic value of a careful symptom evaluation and high sensitive troponin in patients with suspected stable angina pectoris without prior cardiovascular disease.
Madsen DM; Diederichsen ACP; Hosbond SE; Gerke O; Mickley H
Atherosclerosis; 2017 Mar; 258():131-137. PubMed ID: 28031149
[TBL] [Abstract][Full Text] [Related]
17. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
[TBL] [Abstract][Full Text] [Related]
18. The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.
Kim SH; Kim HJ; Han S; Yoo BS; Choi DJ; Kim JJ; Jeon ES; Cho MC; Chae SC; Ryu KH
PLoS One; 2017; 12(12):e0188938. PubMed ID: 29261675
[TBL] [Abstract][Full Text] [Related]
19. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Prognostic Significance of High-Sensitive Troponin I Increase during Hospital Stay in Patients with Acute Myocardial Infarction and Non-Obstructive Coronary Arteries.
Jędrychowska M; Januszek R; Wańha W; Malinowski KP; Kunik P; Trznadel A; Bartuś J; Staszczak B; Januszek SM; Kameczura T; Wojakowski W; Surdacki A; Bartuś S
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32867290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
